Reducing the allergenicity of tropomyosin in shrimp by covalent conjugation with quercetin and chlorogenic acid

• Published in: International journal of biological macromolecules 2024-03, Vol.262 (Pt 2), p.130099-130099, Article 130099
• Main Authors: Ge, Xinyu, Ju, Guangxiu, Lv, Xiaojing, Sui, Xiufen, Zhang, Yalin, Liang, Lifan, Yang, Qingli, Wu, Wei, Lv, Liangtao
• Format: Article
• Language: English
• Subjects: Allergenicity; Allergens - chemistry; Animals; calorimetry; chlorogenic acid; Chlorogenic Acid - chemistry; circular dichroism spectroscopy; Cytokines; epitopes; fluorescence; food industry; Fourier transform infrared spectroscopy; Histamine; Immunoglobulin E - metabolism; immunoglobulin G; interleukin-13; interleukin-4; interleukin-5; Mice; polyacrylamide gel electrophoresis; Polyphenol; Quercetin; shrimp; Shrimp tropomyosin; sodium dodecyl sulfate; Tropomyosin - chemistry; tropomyosins
• ISSN: 0141-8130; 1879-0003
• DOI: 10.1016/j.ijbiomac.2024.130099

The study aimed to assay the allergenicity of shrimp tropomyosin (TM) following covalent conjugation with quercetin (QR) and chlorogenic acid (CA). The structure of the TM-polyphenol covalent conjugates was examined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), circular dichroism (CD), fluorescence, differential scanning calorimetry (DSC), and Fourier Transform infrared spectroscopy (FTIR). Potential allergenicity was evaluated using in vitro and in vivo methods. The results showed that QR and CA induced structural changes in TM through aggregation. RBL-2H3 cell results showed that TM-QR and TM-CA covalent conjugates reduced the release of β-hexosaminidase and histamine, respectively. In the mice model, TM-QR and TM-CA covalent conjugates reduced the level of IgE, IgG, IgG1, histamine, and mMCP-1 in sera. Furthermore, the allergenicity was reduced by suppressing Th2-related cytokines (IL-4, IL-5, IL-13) and promoting Th1-related cytokines (IFN-γ). These research findings demonstrate that the covalent binding of TM with QR and CA, modifies the allergenic epitopes of shrimp TM, thereby reducing its potential allergenicity. This approach holds practical applications in the production of low-allergenicity food within the food industry.